The Nanoro HDSS aims to provide a core framework for clinical trials and also to support the Burkina Faso health authorities in generating epidemiological data that can contribute to the setup and assessment of health interventions. Participants of all ages were recruited from households in Nabaro, a rural area in Burkina Faso. Initial data collection began in 2009 and participants have been followed up every four months, with around 50,000 to 60,000 participants per wave.
Study design
Household panel, Cohort - open
Number of participants at first data collection
61,632 (participants - 2010)
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2009
Primary Institutions
Clinical Research Unit of Nanoro (Institut de Recherche en Sciences de la Santé, IRSS-CRUN)
Profile paper DOI
Funders
Bill & Melinda Gates Foundation
European Union (EU)
European and Developing Clinical Trial Partnership (EDCTP)
GlaxoSmithKline (GSK)
Institute of Tropical Medicine (ITM)
Ongoing?
Yes
Data types collected
Engagement
Keywords
Consortia and dataset groups